|
|
|
|
| LEADER |
01383cam a2200433 4500 |
| 001 |
PPN020848560 |
| 003 |
http://www.sudoc.fr/020848560 |
| 005 |
20170412032600.0 |
| 010 |
|
|
|a 0-8247-8011-6
|b br.
|
| 020 |
|
|
|a US
|b 8828369
|
| 035 |
|
|
|a (OCoLC)490673754
|
| 035 |
|
|
|a ocm18462830
|
| 035 |
|
|
|z ocm20893491
|
| 035 |
|
|
|a ocm20893491
|
| 100 |
|
|
|a 19891116d1989 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a a z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Genetic engineering technology in industrial pharmacy
|b Texte imprimé
|e principles and applications
|f edited by John M. Tabor
|
| 210 |
|
|
|a New York
|c Marcel Dekker
|d cop. 1989
|
| 215 |
|
|
|a 1 vol. (X-359 p.)
|c ill.
|d 24 cm
|
| 320 |
|
|
|a Notes bibliogr. Index
|
| 606 |
|
|
|3 PPN02756987X
|a Génie génétique
|2 rameau
|
| 606 |
|
|
|3 PPN029722373
|a Technologie pharmaceutique
|2 rameau
|
| 606 |
|
|
|3 PPN040711226
|a Génie génétique
|2 fmesh
|
| 606 |
|
|
|3 PPN040787974
|a Technologie pharmaceutique
|2 fmesh
|
| 676 |
|
|
|a 615.19
|
| 680 |
|
|
|a TP248.6
|b .G464 1989
|
| 686 |
|
|
|a QH 442
|b G3294 1989
|2 usnlm
|
| 702 |
|
0 |
|3 PPN116670894
|a Tabor
|b John M.
|4 340
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20110316
|g AFNOR
|
| 979 |
|
|
|a SAN
|
| 930 |
|
|
|5 441092101:336945671
|b 441092101
|a 59119
|j u
|
| 998 |
|
|
|a 258435
|
Nantilus
